Upload

Loading...

  1. 157

    Yoseline's story -- USA

  2. 158

    Complex realities of global healthcare

  3. 159

    Novartis CEO Joe Jimenez: What do you tell a team that has failed?

  4. 160

    Each Voice Counts - The Experts

  5. 161

    The voice of advanced breast cancer patients on The Balancing Act® show

  6. 162

    The Next Generation Scientist 2012

  7. 163

    Novartis CEO Joe Jimenez: The best advice I ever got

  8. 164

    Each Voice Counts - The Family

  9. 165

    Periodic fever syndromes

  10. 166

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  11. 167

    A lifelong challenge: periodic fever syndromes

  12. 168

    Connections

  13. 169

    Each Voice Counts - The Women: Part 1

  14. 170

    Each Voice Counts - The Women: Part 2

  15. 171

    Unanswered questions about living with advanced breast cancer

  16. 172

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  17. 173

    Novartis International Biotechnology Leadership Camp 2012

  18. 174

    Journey of Chronic Myeloid Leukemia (CML)

  19. 175

    A look at the past decade in GIST: Chapter 6

  20. 176

    A look at the past decade in GIST: Chapter 5

  21. 177

    A look at the past decade in GIST: Chapter 4

  22. 178

    Vision loss due to Retinal Vein Occlusion (RVO)

  23. 179

    Vision loss due to Diabetic Macular Edema (DME)

  24. 180

    Vision loss due to wet age-related macular degeneration (wet AMD)

  25. 181

    A look at the past decade in GIST: Chapter 3

  26. 182

    Building the next generation of scientists

  27. 183

    A look at the past decade in GIST: Chapter 2

  28. 184

    A look at the past decade in GIST: Chapter 1

  29. 185

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  30. 186

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  31. 187

    Advanced breast cancer 101

  32. 188

    The mTOR pathway in ER+ advanced breast cancer

  33. 189

    Life in a Circle

  34. 190

    Understanding advanced breast cancer

  35. 191

    A Gift for Living

  36. 192

    The Villages Miles Away

  37. 193

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  38. 194

    Innovating to help eliminate malaria

  39. 195

    Malaria milestone video message

  40. 196

    Leo and Kya, friends against malaria

  41. 197

    The need for progress: what if?

  42. 198

    The myelofibrosis educational journey

  43. 199

    Understanding the progression of myelofibrosis

  44. 200

    Understanding the management of myelofibrosis

  45. 201

    The myelofibrosis disease burden

  46. 202

    The disease pathway associated with myelofibrosis

  47. 203

    New research developments in myelofibrosis

  48. 204

    Delivery of child-friendly antimalarial hits the 100 million mark

  49. 205

    Treating India's Leprosy patients

  50. 206

    Treating leprosy, caring for patients

  51. 207

    "SMS for Life" is expanding

  52. 208

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  53. 209

    Critical issues facing the advanced breast cancer patient community

  54. 210

    Advice to newly diagnosed advanced breast cancer patients

  55. 211

    Insight into the advanced breast cancer patient journey

  56. 212

    Pioneering an innovative social business model to fight malaria

  57. 213

    New media: drivers of democratization and development?

  58. 214

    What is it like living with myelofibrosis (MF)?

  59. 215

    What is the prognosis of myelofibrosis (MF)?

  60. 216

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  61. 217

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  62. 218

    What is myelofibrosis (MF)?

  63. 219

    How is the patient journey for advanced breast cancer patients different?

  64. 220

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  65. 221

    What is progression free survival and why is it important?

  66. 222

    What guidance do you give patients and family coping with advanced breast cancer?

  67. 223

    What insights can you share with newly diagnosed patients?

  68. 224

    Molecular pathways:The future of research at NIBR

  69. 225

    The importance of organ donation

  70. 226

    Novartis BioCamp 2011 (German)

  71. 227

    Novartis BioCamp 2011 (French)

  72. 228

    How is research in advanced breast cancer evolving?

  73. 229

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  74. 230

    What can a patient expect if diagnosed with advanced breast cancer?

  75. 231

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  76. 232

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  77. 233

    How does the advanced breast cancer treatment journey differ for patients?

  78. 234

    Novartis Be Healthy

  79. 235

    Novartis BioCamp 2011

  80. 236

    A sign from above

  81. 237

    Charlie

  82. 238

    Happy endings

  83. 239

    Herpes #1

  84. 240

    Herpes it's black and white

  85. 241

    Herpes the Ninja virus

  86. 242

    Magical elves with HSV

  87. 243

    Open happiness

  88. 244

    Play it smart

  89. 245

    Quarantine

  90. 246

    Strings

  91. 247

    Ah! Real herpes

  92. 248

    Down there

  93. 249

    Don't let herpes put you off

  94. 250

    Arogya Parivar: A social business model to improve health in rural India

  95. 251

    Living with multiple myeloma

  96. 252

    What are the symptoms of myelofibrosis (MF)?

  97. 253

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  98. 254

    Animals & Research: Think how far we've come

  99. 255

    SMS for Life

Sign in to add this to Watch Later

Add to